Coya Therapeutics (COYA) Research & Development (2022 - 2026)

Coya Therapeutics has disclosed Research & Development across 5 years of filings, most recently posting $5.0 million for Q2 2026.

• In Q2 2026, Research & Development rose 37.33% year-over-year to $5.0 million; the TTM figure through Jun 2026 stood at $17.0 million (up 30.26% YoY), while the FY2025 annual figure was $16.7 million, up 41.03% from the prior year.
• Research & Development came in at $5.0 million for Q2 2026 at Coya Therapeutics, up from $4.1 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $5.2 million in Q1 2025 to a low of $708032.0 in Q4 2022.
• Average Research & Development over 5 years is $2.6 million, with a median of $2.1 million recorded in 2024.
• Year-over-year, Research & Development decreased 26.21% in 2023 and soared 327.56% in 2024.
• Over 5 years, Research & Development stood at $708032.0 in 2022, then jumped by 127.34% to $1.6 million in 2023, then advanced by 20.37% to $1.9 million in 2024, then soared by 155.0% to $4.9 million in 2025, then gained by 1.83% to $5.0 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $5.0 million in Q2 2026, $4.1 million in Q1 2026, and $4.9 million in Q4 2025.